The Role of NK Cells and T Cells in the Rejection of Embryonic Stem Cell-Derived Tissues

  • Bob Miyake
  • Nicholas Zavazava
Part of the Stem Cell Biology and Regenerative Medicine book series (STEMCELL)


Embryonic stem (ES) cells provide a unique opportunity for the establishment of new cell-based therapies that could benefit human health in the future. However, before that step can be taken, we need to better understand how to manipulate the differentiation of stem cells into cell lineages of interest and to define the immunological characteristics of these cells in the context of allogeneic transplantation. Here, we will discuss the interaction of ES cell progenitors with alloreactive T cells and NK cells and discuss how low MHC expression by ES cell derivatives may be exploited for therapies in humans.


Major Histocompatibility Complex Embryonic Stem Embryonic Stem Cell Human Leukocyte Antigen Major Histocompatibility Complex Class 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



This work would not have been possible without grants NIH/NHLBI 5R01HL073015-08 and the VA Merit Review Award 1I01BX001125-01


  1. 1.
    Chinen J, Buckley RH (2010) Transplantation immunology: solid organ and bone marrow. J Allergy Clin Immunol 125:S324–S335PubMedCrossRefGoogle Scholar
  2. 2.
    Zavazava N, Kabelitz D (2000) Alloreactivity and apoptosis in graft rejection and transplantation tolerance. J Leuko Biol 68:167–174PubMedGoogle Scholar
  3. 3.
    Chan KM, Bonde S, Klump H, Zavazava N (2008) Hematopoiesis and immunity of HOXB4-transduced embryonic stem cell-derived hematopoietic progenitor cells. Blood 111:2953–2961PubMedCrossRefGoogle Scholar
  4. 4.
    Drukker M, Katz G, Urbach A, Schuldiner M, Markel G, Itskovitz-Eldor J, Reubinoff B, Mandelboim O, Benvenisty N (2002) Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci U S A 99:9864–9869PubMedCrossRefGoogle Scholar
  5. 5.
    Bonde S, Chan KM, Zavazava N (2008) ES-cell derived hematopoietic cells induce transplantation tolerance. PLoS ONE 3:e3212PubMedCrossRefGoogle Scholar
  6. 6.
    Kim EM, Zavazava N (2010) Low antigenicity of hematopoietic progenitor cells derived from human ES cells. Transplant Res Risk Manage 2:15–22Google Scholar
  7. 7.
    Ladhoff J, Bader M, Brosel S, Effenberger E, Westermann D, Volk HD, Seifert M (2009) Low immunogenicity of endothelial derivatives from rat embryonic stem cell-like cells. Cell Res 19:507–518PubMedCrossRefGoogle Scholar
  8. 8.
    Klein J, Sato A (2000) The HLA system. First of two parts. N Engl J Med 343:702–709PubMedCrossRefGoogle Scholar
  9. 9.
    Tabayoyong WB, Zavazava N (2007) Soluble HLA revisited. Leuk Res 31:121–125PubMedCrossRefGoogle Scholar
  10. 10.
    Loiseau P, Busson M, Balere ML et al (2007) HLA association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival. Biol Blood Marrow Transplant 13:965–974PubMedCrossRefGoogle Scholar
  11. 11.
    Baxter-Lowe LA, Maiers M, Spellman SR, Haagenson MD, Wang T, Fernandez-Vina M, Marsh SG, Horowitz M, Hurley CK (2009) HLA-A disparities illustrate challenges for ranking the impact of HLA mismatches on bone marrow transplant outcomes in the United States. Biol Blood Marrow Transplant 15:971–981PubMedCrossRefGoogle Scholar
  12. 12.
    Shlomchik WD (2007) Graft-versus-host disease. Nat Rev Immunol 7:340–352PubMedCrossRefGoogle Scholar
  13. 13.
    Bonde S, Zavazava N (2006) Immunogenicity and engraftment of mouse embryonic stem cells in allogeneic recipients. Stem Cells 24:2192–2201PubMedCrossRefGoogle Scholar
  14. 14.
    Koch KS, Son KH, Maehr R, Pellicciotta I, Ploegh HL, Zanetti M, Sell S, Leffert HL (2006) Immune-privileged embryonic Swiss mouse STO and STO cell-derived progenitor cells: major histocompatibility complex and cell differentiation antigen expression patterns resemble those of human embryonic stem cell lines. Immunology 119:98–115PubMedCrossRefGoogle Scholar
  15. 15.
    de Preynat-Seauve O RC, Tirefort D, Ferrari-Lacraz S, Krause KH, Villard J (2009) Neural progenitors derived from human embryonic stem cells are targeted by allogeneic T and natural killer cells. J Cell Mol Med 13:3556–3569PubMedCrossRefGoogle Scholar
  16. 16.
    Tabayoyong WB, Salas JG, Bonde S, Zavazava N (2009) HOXB4-transduced embryonic stem cell-derived Lin-c-kit + and Lin-Sca-1 + hematopoietic progenitors express H60 and are targeted by NK cells. J Immunol 183:5449–5457PubMedCrossRefGoogle Scholar
  17. 17.
    Li L, Baroja ML, Majumdar A et al (2004) Human embryonic stem cells possess immune-privileged properties. Stem Cells 22:448–456PubMedCrossRefGoogle Scholar
  18. 18.
    Fandrich F, Lin X, Chai GX et al (2002) Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning. Nat Med 8:171–178PubMedCrossRefGoogle Scholar
  19. 19.
    Robertson NJ, Brook FA, Gardner RL, Cobbold SP, Waldmann H, Fairchild PJ (2007) Embryonic stem cell-derived tissues are immunogenic but their inherent immune privilege promotes the induction of tolerance. Proc Natl Acad Sci U S A 104:20920–20925PubMedCrossRefGoogle Scholar
  20. 20.
    Koch CA, Geraldes P, Platt JL (2008) Immunosuppression by embryonic stem cells. Stem Cells 26:89–98PubMedCrossRefGoogle Scholar
  21. 21.
    Lanier LL (2005) NK cell recognition. Annu Rev Immunol 23:225–274PubMedCrossRefGoogle Scholar
  22. 22.
    Ruggeri L, Mancusi A, Burchielli E, Perruccio K, Aversa F, Martelli MF, Velardi A (2006) Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation. Semin Cancer Biol 16:404–411PubMedCrossRefGoogle Scholar
  23. 23.
    Ruggeri L, Capanni M, Mancusi A, Martelli MF, Velardi A (2005) The impact of donor natural killer cell alloreactivity on allogeneic hematopoietic transplantation. Transpl Immunol 14:203–206PubMedCrossRefGoogle Scholar
  24. 24.
    Dong Z, Cruz-Munoz ME, Zhong MC, Chen R, Latour S, Veillette A (2009) Essential function for SAP family adaptors in the surveillance of hematopoietic cells by natural killer cells. Nat Immunol 10:973–980PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Division of Allergy and Immunology, Department of Internal MedicineUniversity of Iowa Hospitals and Clinics, VAHCS lowa CityIowa CityUSA

Personalised recommendations